According to MARTIN MIDSTREAM PARTNERS L.P.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 10:56 AM, company Director, Taylor Sharon L disclosed buying 416 shares at a cost of $2.91. At the time of this transaction (Jan 11), this trade was worth $1,212 in total. […]
Thursday January 13 2022, 10:42 PM EST | Posted in
Business,
Stocks |
Read More »
According to MARTIN MIDSTREAM PARTNERS L.P.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 10:56 AM, company Chief Medical Officer, Martin Ruben S disclosed buying 485 shares at a cost of $2.91. At the time of this transaction (Jan 11), this trade was worth $1,413 […]
Thursday January 13 2022, 10:41 PM EST | Posted in
Business,
Stocks |
Read More »
According to Anixa Biosciences Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:54 AM, company Director, Titterton Lewis H Jr disclosed buying 2,000 shares at a cost of $3.20. At the time of this transaction (Jan 11), this trade was worth $6,400 in total. […]
Thursday January 13 2022, 10:40 PM EST | Posted in
Business,
Stocks |
Read More »
According to AMN HEALTHCARE SERVICES INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:28 PM, company Chief Executive Officer, Salka Susan R disclosed selling 14,309 shares at a cost of $109.47. At the time of this transaction (Jan 10), this trade was worth $1,566,361 […]
Thursday January 13 2022, 3:10 PM EST | Posted in
Business,
Stocks |
Read More »
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:16 PM, company Chief Accounting Officer, Whitten Jessica disclosed selling 279 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $2,690 in total. […]
Thursday January 13 2022, 3:09 PM EST | Posted in
Business,
Stocks |
Read More »
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Chief Operating and, Cole Jason disclosed selling 3,387 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $32,659 in total. […]
Thursday January 13 2022, 3:08 PM EST | Posted in
Business,
Stocks |
Read More »
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Chief Operating and, Cole Jason disclosed selling 1,584 shares at a cost of $9.40. At the time of this transaction (Jan 10), this trade was worth $14,893 in total. […]
Thursday January 13 2022, 3:07 PM EST | Posted in
Business,
Stocks |
Read More »
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Director, Leschly Nick disclosed selling 5,068 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $48,869 in total. As of […]
Thursday January 13 2022, 3:06 PM EST | Posted in
Business,
Stocks |
Read More »
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Director, Leschly Nick disclosed selling 2,369 shares at a cost of $9.40. At the time of this transaction (Jan 10), this trade was worth $22,274 in total. As of […]
Thursday January 13 2022, 3:05 PM EST | Posted in
Business,
Stocks |
Read More »
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company President and CEO, Obenshain Andrew disclosed selling 4,683 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $45,156 in total. […]
Thursday January 13 2022, 3:04 PM EST | Posted in
Business,
Stocks |
Read More »